Close up of microscope in laboratory setting with overlaid green abstract pattern on dark background

CLDN18.2:
Test and interpret with confidence

Help identify a new subpopulation of patients with gastric / gastroesophageal junction (G/GEJ) adenocarcinoma.

Peer perspectives

Hear from some of the world’s leading pathologists discussing how they test, interpret, and report CLDN18.2 expression.

overlayvideoimage

Home

Video 1 Description

Home

closeicon

Screen grab of Dr. Matteo Fassan video "What Is CLDN18.2?"

video overlay title2

closeicon

video overlay title3

video overlay1 description title new

video overlay1 description

What Is CLDN18.2?

Matteo Fassan, MD, PhD

overlayvideoimage

Video1 Title1

video3 overlay description3 title

video3 overlay description3

Home

closeicon

Screen grab of Dr. Takeshi Kutawa video "How to Prepare Samples for CLDN18.2 Testing"

video overlay title2

closeicon

video overlay title3

video overlay4 description titlenew

video overlay description4new

How to Prepare Samples for CLDN18.2 Testing

Takeshi Kuwata, MD, PhD

overlayvideoimage

Video1 Title1

Video 6 Description Title

Video 6 Description

video overlay title1

closeicon

Screen grab of Dr. Christoph Rocken video "How to Test for CLDN18.2"

video overlay title2

closeicon

video overlay title3

video overlay description 9 title

video overlay description

How to Test for CLDN18.2

Christoph Röcken, MD

overlayvideoimage

Video1 Title

video1 description1

video overlay title4

closeicon

Screen grab of Dr. Josef H. Ruschoff video "How to Interpret CLDN18.2"

video overlay4 title

closeicon

video overlay4 title4

video overlay5 description

How to Interpret CLDN18.2

Josef H. Rüschoff, MD

overlayvideoimage

Video1 Title1

Video 1 Description

video overlay title1

closeicon

Screen grab of Dr. Kristina Matkowskyj video "How to Report CLDN18.2"

video overlay title2

closeicon

video overlay title3

video overlay1 description11 title

video overlay4 description11

How to Report CLDN18.2

Kristina A. Matkowskyj, MD, PhD

CLDN18.2 Expert Committee

The experts above have been contracted as paid advisors through Astellas Pharma Inc. and have received compensation for their time.

The content on this website has been created by Astellas Pharma Inc. and may or may not reflect the views of the experts shown above unless explicitly specified.

CLDN18.2, claudin 18 isoform 2; G/GEJ, gastric/gastroesophageal junction.

stain-interpretation-home-mobile

Review whole slide images and test your interpretation skills

Abstract pattern of aqua green circles

Stay up to date on CLDN18.2

In case of any adverse event please contact safety.at@astellas.com.